Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.12 USD | +1.73% | -0.24% | -44.77% |
22/05 | HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating | MT |
14/05 | Acelyrin, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.77% | 41Cr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.82% | 2.2TCr | |
-10.12% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr | |
+77.64% | 887.31Cr |
- Stock Market
- Equities
- SLRN Stock
- News Acelyrin, Inc.
- Wells Fargo Raises ACELYRIN's Price Target to $13 From $11, Keeps Equalweight Rating